Adjunct Faculty
Adjunct faculty typically have an academic or research appointment at another institution and contribute or collaborate with one or more School of Medicine faculty members or programs.
Adjunct rank detailsAudrey Merriam, MD, MS
she/her/hers
Associate Professor AdjunctAbout
Research
Publications
2025
Gestational Weight Gain and Hypertensive Disorders of Pregnancy With Prepregnancy and Early Pregnancy Glucagon-Like Peptide-1 Receptor Agonist Exposure.
Pondugula N, Culhane J, Lundsberg L, Partridge C, Merriam A. Gestational Weight Gain and Hypertensive Disorders of Pregnancy With Prepregnancy and Early Pregnancy Glucagon-Like Peptide-1 Receptor Agonist Exposure. Obstetrics And Gynecology 2025 PMID: 40609095, PMCID: PMC12233158, DOI: 10.1097/aog.0000000000005995.Peer-Reviewed Original ResearchGestational weight gainPregestational diabetesGLP-1RAGLP-1RAsAssociated with lower oddsWeight managementHypertensive disordersRisk of gestational weight gainAssociated with gestational weight gainControl groupOdds ratioHypertensive disorders of pregnancyGlucagon-like peptide-1 receptor agonistsRecommended gestational weight gainWeight gainPeptide-1 receptor agonistsAssociated with decreased riskPregestational diabetes mellitusDisorders of pregnancyLower oddsRetrospective cohort studyElectronic medical record queryGLP-1RA useAssociated with decreased oddsCrude odds ratio
2024
The early COVID-19 pandemic period and associated gestational weight gain
Madein A, Lundsberg L, Culhane J, Partridge C, Son M, Merriam A. The early COVID-19 pandemic period and associated gestational weight gain. Journal Of Perinatal Medicine 2024, 53: 2-8. PMID: 39485230, DOI: 10.1515/jpm-2024-0088.Peer-Reviewed Original ResearchGestational weight gainGestational ageWeight gainAssociated with weight gainInstitute of MedicineMaternal weight gainWeight gain riskRetrospective cohort studyInstitute of Medicine recommendationsTertiary care hospitalNo significant differenceEarly pandemic periodCohort studyPrimary outcomeMedical record dataCare hospitalPandemic groupPandemic epochSignificant differenceLogistic regressionElectronic medical record dataExposure groupMultinominal logistic regressionPandemic periodAgeLidocaine patches after cesarean sections: a randomized control trial
Arkfeld C, Starosta A, Esencan E, Athens Z, Lundsberg L, Merriam A. Lidocaine patches after cesarean sections: a randomized control trial. American Journal Of Obstetrics & Gynecology MFM 2024, 6: 101536. PMID: 39491590, DOI: 10.1016/j.ajogmf.2024.101536.Peer-Reviewed Original ResearchPost-operative pain scoresLidocaine patch groupVisual analog scalePost-operative day 1Pain scoresLidocaine patchCesarean sectionAnalog scalePatch groupDay 1Post-cesarean pain managementPost-operative hospital stayVisual analog pain scoreDay 3Day 2Day 4Controlled TrialsControlled trials of patientsAnalog pain scoresBaseline maternal characteristicsTrial of patientsOpiate use disorderPain management strategiesPost-operative periodAbdominal hernia repairDesign, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study
Group T, Scholtens D, LeBlanc E, Vesco K, Amy D, Bays K, Massimino S, Robinson S, Schell K, Walters G, Hillier T, Oshiro C, Cordero S, Howick C, Kim L, Martinez Y, Pishchalenko O, Wastlova V, Zork N, Mourad M, Lonier J, Reddy U, Acevedo J, Castillo J, Gomez M, Peguero B, Facco F, Feghali M, Bocan H, Stramowski S, Powe C, Edlow A, Barth W, Nathan D, Azevedo R, Baez A, Iroajanma C, Larkin M, Maya J, Michalopoulos C, Neamonitaki N, Thangthaeng N, Yee L, Lowe W, Grobman W, Szmuilowicz E, Aguirre A, Guevara E, Mallett G, Matos S, Tyagi S, Spadola A, Catalano P, Azimirad A, Werner E, Rouse D, Malloy M, Parra F, Sherr J, Merriam A, Bitterman S, Considine E, Leventhal J, Perley L, Rink L, Steffen A, Thompson B, Zgorski M, Steffes M, Arends V, Killeen A, Siddique J, Bustamante P, Cheung Y, Freeze C, Grott T, Kuang A, Tull M, Linder B. Design, rationale and protocol for Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs): an observational cohort study. BMJ Open 2024, 14: e084216. PMID: 38851233, PMCID: PMC11163666, DOI: 10.1136/bmjopen-2024-084216.Peer-Reviewed Original ResearchConceptsLarge-for-gestational-age birth weightMetabolic outcomesLarge-for-gestational-ageDiagnosis of gestational diabetesOral glucose tolerance testAdverse pregnancy outcomesVanderbilt University Institutional Review BoardCourse of pregnancyObservational cohort studyGlucose tolerance testNational Institute of DiabetesDigestive and Kidney DiseasesGDM treatmentWeeks gestationDetect such abnormalitiesPerinatal outcomesGDM screeningInstitutional review boardGestational diabetesFirst-trimesterPregnancy outcomesEarly pregnancyGlucose abnormalitiesBirth weightPregnant adultsFor Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]
Mason-Otey A, Lundsberg L, Culhane J, Merriam A. For Patients Undergoing an Induction of Labor, Does Increased Body Mass Index Necessitate Higher Doses of Misoprostol? [ID 2683640]. Obstetrics And Gynecology 2024, 143: 46s-46s. DOI: 10.1097/01.aog.0001013576.14925.24.Peer-Reviewed Original ResearchInduction of laborBody mass indexBody mass index categoriesDose of misoprostolMisoprostol doseClass IIIMass indexProlonged induction of laborClass IIAssociated with increased BMIClass IIncreased BMIPre-gestational diabetesClass II obesityClass I obesityRetrospective cohort analysisMisoprostol administrationObese patientsII obesityMisoprostolInvestigate safetyHigh dosesPrimary outcomeCohort analysisPatientsNoninvasive single‐cell‐based prenatal genetic testing: A proof of concept clinical study
Bellair M, Amaral E, Ouren M, Roark C, Kim J, O'Connor A, Soriano A, Schindler M, Wapner R, Stone J, Tavella N, Merriam A, Perley L, Breman A, Beaudet A. Noninvasive single‐cell‐based prenatal genetic testing: A proof of concept clinical study. Prenatal Diagnosis 2024, 44: 304-316. PMID: 38411249, DOI: 10.1002/pd.6529.Peer-Reviewed Original ResearchConceptsNoninvasive prenatal genetic testingLow-risk pregnanciesConcept clinical studyCopy number analysisPrenatal genetic testingNext-generation sequencingPlacental mosaicismMaternal bloodAneuploidy resultsMeasures of test performanceCK stainingCVS casesClinical studiesGenetic testingNucleated cellsTrophoblastRed cellsNumber analysisPregnancyBloodDeletions/duplicationsAneuploidyDeletionAmniocentesisCellsAbsence of adverse maternal and neonatal outcomes in patients with 1 or 2 abnormal values during early glucose tolerance testing
Geng B, Lundsberg L, Culhane J, Merriam A. Absence of adverse maternal and neonatal outcomes in patients with 1 or 2 abnormal values during early glucose tolerance testing. American Journal Of Obstetrics And Gynecology 2024, 230: e103-e107. PMID: 38242338, DOI: 10.1016/j.ajog.2024.01.007.Peer-Reviewed Original Research284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes
Pifer B, Geng B, Lundsberg L, Culhane J, Partridge C, Merriam A. 284 Postpartum diabetes screening rates and 1-year outcomes for individuals with early onset gestational diabetes. American Journal Of Obstetrics And Gynecology 2024, 230: s163-s164. DOI: 10.1016/j.ajog.2023.11.306.Peer-Reviewed Original Research
2023
Reply: The Risk Factor for Maternal Morbidity is Racism, Not Race
Merriam A, Metz T, Allshouse A, Silver R, Haas D, Grobman W, Simhan H, Wapner R, Wing D, Mercer B, Parry S, Reddy U, investigators N. Reply: The Risk Factor for Maternal Morbidity is Racism, Not Race. American Journal Of Perinatology 2023, 41: e3274-e3275. PMID: 37863072, DOI: 10.1055/a-2195-6914.Peer-Reviewed Original ResearchStructural racismSystemic racismRacismSocial constructRacial categoriesSocial determinantsEffect of raceRacial groupsRaceMaternal health outcomesAuthor’s pointWhite participantsImplicit biasDiscussionAsiansHealth careInequitiesResearch publicationsCritical concernConcernHealth outcomesUnderlying reasonsThromboembolic Disorders
Merriam A, Pettker C. Thromboembolic Disorders. 2023, 123-133. DOI: 10.1002/9781119636540.ch15.Peer-Reviewed Original ResearchVenous thromboembolismPulmonary embolismLeading causeDeep venous thrombosisCommon physical symptomsOperative vaginal deliveryPregnancy-specific risk factorsMaternal morbidityCesarean deliveryMultiple gestationsMaternal deathsVaginal deliveryVenous thrombosisPostpartum hemorrhageMaternal mortalityNonpregnant individualsThrombotic riskPostpartum periodRisk factorsThromboembolic disordersLow prevalencePhysical symptomsPregnancySymptomsThromboembolism